Clinical Data Shares Rise on Plans for 3-for-2 Stock Split | GenomeWeb
NEW YORK (GenomeWeb News) - Clinical Data’s board of directors yesterday approved a 3-for-2 stock split that will give company stockholders one new share of common stock for every two shares they own.
 
The news drove the company's share price up nearly 13 percent to close at $34.38 yesterday. In late morning trading today, the company's shares had pulled back slightly to $33.96. 
 
The split will occur Sept. 24, and the dividends will be distributed on Oct. 2, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.